The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon Adenocarcinoma.

Cancer Rep (Hoboken) · 2026 · PMC12928083 · PMID 41725032

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Because the existing serum biomarkers lacked high sensitivity and specificity for the surveillance of metastatic or recurrent disease in colon adenocarcinoma, it may be significant to determine the cut‐off value of CD276 and use as a biomarker for early alarming tumor recurrence after surgery [ 24 , 25 , 26 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.